Axogen, Inc. (AXGN): R&D Expense
$32.88M
Year ended 2025-12-31
$36.05M
Trailing 12 months to 2026-06-30
+8.7%
3-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $32.88M | +18.4% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $27.77M | +1.6% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $27.34M | +6.7% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $25.63M | n/c | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $24.18M | +35.5% | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | $17.85M | +1.9% | 2023-03-14, From 2020-01-01 |
| 2019-12-31 | $17.51M | +48.8% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $11.77M | +75.7% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $6.70M | +59.0% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $4.21M | +30.1% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $3.24M | +6.7% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $3.03M | +42.7% | 2016-02-29, From 2014-01-01 |
| 2013-12-31 | $2.13M | +48.9% | 2015-03-05, From 2013-01-01 |
| 2012-12-31 | $1.43M | +104.7% | 2014-03-06, From 2012-01-01 |
| 2011-12-31 | $697.4K | +59.9% | 2013-08-07, From 2011-01-01 |
| 2010-12-31 | $436.0K | n/a | 2012-03-15, From 2010-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Axogen, Inc. (AXGN) | 2025-12-31 | $32.88M | +18.4% |
| InMode Ltd. (INMD) | 2025-12-31 | $13.32M | +1.4% |
| Outset Medical, Inc. (OM) | 2025-12-31 | $21.23M | -44.7% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $7.57M | +59.3% |
| Vaso Corp (VASO) | 2025-12-31 | $728.0K | -14.5% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | $19.14M | +41.2% |
| TransMedics Group, Inc. (TMDX) | 2025-12-31 | $69.06M | +23.4% |
| Electromed, Inc. (ELMD) | 2026-06-30 | $1.31M | +31.9% |
| Iridex Corp (IRIX) | 2026-01-03 | $3.67M | -32.7% |
Compare AXGN, INMD, OM, BLFS side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗